Drug Profile
Research programme: endocrine disorders therapy - Erasmus Medical Center/Ipsen
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Erasmus Medical Center; Ipsen
- Developer Erasmus MC; Ipsen
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Endocrine disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Endocrine-disorders in France
- 16 Jul 2016 No recent reports of development identified for preclinical development in Endocrine-disorders in Netherlands
- 06 Dec 2007 Preclinical trials in Endocrine disorders in France (unspecified route)